Sergei Petukhov, DVM
Chief Executive Officer
Max Temnik, PhD
Founder & President
Sergey Gurin, MBA
Executive Vice President
Leonid Magidenko, MD
Vice President, Products
Guided by our founders' track record in establishing successful companies, we are building a team of industry-tempered, mission-focused specialists who enhance our innovative approach and share our commitments.
Advisers
Robert "Al" Beardsley, PhD
Chemistry, Redox, Chair
Andie Collier
Regulatory Affairs
Judy Schneider, PhD
Clinical Operations
Dennis Priley, PhD
Inorganic Medicinal Chemistry
James Blackledge, PhD
Bioanalytical Chemistry
Michael D. Story, PhD
Cancer & Radiation Biology
Michale Petronek, PhD
Metallome & Redox Biology
Douglas Spritz, PhD
Cellular & Redox Biology